MMWR Recomm Rep. 1991 Nov 22;40(RR-13):1-25.
The following statement updates all previous recommendations on protection against hepatitis B virus infection, including use of hepatitis B vaccine and hepatitis B immune globulin for prophylaxis against hepatitis B virus infection (MMWR 1985;34:313-24,329-35, MMWR 1987;36:353-66, and MMWR 1990:39 [No.RR-2]:8-19) and universal screening of pregnant women to prevent perinatal hepatitis B virus transmission (MMWR 1988;37:341-46,51, and MMWR 1990;39[No.RR-2]:8-19). Recommendations concerning the prevention of other types of viral hepatitis are found in MMWR 1990;39(No.RR-2):1-8, 22-26. This document provides the rationale for a comprehensive strategy to eliminate transmission of hepatitis B virus in the United States. This prevention strategy includes making hepatitis B vaccine a part of routine vaccination schedules for all infants.
以下声明更新了此前所有关于预防乙型肝炎病毒感染的建议,包括使用乙型肝炎疫苗和乙型肝炎免疫球蛋白预防乙型肝炎病毒感染(《发病率与死亡率周报》1985年;34:313 - 24,329 - 35,《发病率与死亡率周报》1987年;36:353 - 66,以及《发病率与死亡率周报》1990年;39[第RR - 2号]:8 - 19),以及对孕妇进行普遍筛查以预防围产期乙型肝炎病毒传播(《发病率与死亡率周报》1988年;37:341 - 46,51,以及《发病率与死亡率周报》1990年;39[第RR - 2号]:8 - 19)。关于预防其他类型病毒性肝炎的建议见《发病率与死亡率周报》1990年;39(第RR - 2号):1 - 8, 22 - 26。本文件阐述了在美国消除乙型肝炎病毒传播的全面策略的基本原理。该预防策略包括将乙型肝炎疫苗纳入所有婴儿的常规疫苗接种计划。